Low levels of PGC-1α disrupt redox homeostasis, exacerbate inflammation, and are linked to metabolic syndrome, such as obesity, type 2 diabetes, cardiovascular diseases, and other related conditions [52]. This evidence concerns the gene PPARGC1A and cardiovascular disorder.